(Press-News.org) A recent study involving researchers at Murdoch University’s Health Futures Institute has revealed that moderate-intensity exercise can significantly influence appetite-related hormones and perceptions in males with obesity.
The study, titled “Acute effect of exercise on appetite-related factors in males with obesity,” provides new insights into how exercise can aid appetite control and weight management.
One of the study authors, Associate Professor Timothy Fairchild from Murdoch’s School of Allied Health, said the study confirms their previous work showing the benefits of incorporating regular exercise into daily routines for individuals looking to manage their weight and improve their overall health.
“People understand that exercise helps ‘burn energy’. A lot of people assume that exercise also increases hunger and energy intake afterwards,” Associate Professor Timothy Fairchild said.
“We have previously shown, using high-intensity exercise, that this is not the case.
“This latest study shows that even moderate-intensity exercise can have immediate and beneficial effects on appetite control in males with obesity.”
The study not only assessed food intake and appetite, but also measured changes in hormones which help to regulate appetite.
“Despite a strong focus on weight loss drugs in society at present, this study shows that lifestyle factors still have a strong and relevant role in helping people to live their healthiest life,” Associate Professor Fairchild said.
“In fact, the hormones which have been shown to increase after exercise, are the same hormones which the most successful weight loss drugs are mimicking.”
“The added benefit of exercise is that you also receive the additional physical and mental health benefits of exercise”.
The full study Acute effect of exercise on appetite-related factors in males with obesity: A pilot study can be found in Physiological Reports journal.
END
Moderate exercise keeps appetite at bay
2025-01-29
ELSE PRESS RELEASES FROM THIS DATE:
Cancer drugs linked to severe chronic peripheral nerve pain for 4 in every 10 patients
2025-01-29
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the available evidence, published in the open access journal Regional Anesthesia & Pain Medicine.
Notwithstanding wide regional variations, platinum based drugs, taxanes, and lung cancer seem to be associated with the highest rates of persistent painful neuropathy, lasting at least 3 months, the findings suggest, prompting the researchers to call for tailored approaches to pain ...
Lack of essential vitamins and minerals common in people with type 2 diabetes
2025-01-29
Micronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is common in people with type 2 diabetes, finds a pooled data analysis of the available evidence, published in the open access journal BMJ Nutrition Prevention & Health.
A lack of vitamin D is the most common ‘missing’ micronutrient, overall, the findings indicate, with women at greater risk than men of these deficiencies, dubbed 'hidden hunger.'
Genetic predisposition, various environmental factors, sedentary ...
Calorie labels on menus could make eating disorders worse
2025-01-29
Calorie labels on restaurant menus are negatively impacting people with eating disorders, according to a new study published today in the BMJ Public Health.
The review, which is the first of its kind, is led by researchers at King’s College London. It found that individuals who have been diagnosed with an eating disorder changed their behaviours if presented with a menu featuring calorie labels.
This included avoiding restaurants, triggering eating disorder thoughts and paying more attention to calorie labels as identified by eye tracking research.
The research found that some people with eating disorders reported that seeing menu labels reinforced ...
Artificial intelligence model identifies potential risk genes for Parkinson’s disease
2025-01-28
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson’s disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.
The npj Parkinson’s Disease report uses an approach called “systems biology,” which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical and patient datasets to identify patterns that may not be obvious from analyzing ...
A new register with thousands of entangled nuclei to scale quantum networks
2025-01-28
In a groundbreaking achievement for quantum technologies, researchers at the Cavendish Laboratory, University of Cambridge, have created a functional quantum register using the atoms inside a semiconductor quantum dot.
Published in Nature Physics, the work demonstrates the introduction of a new type of optically connected qubits—a critical advance in the development of quantum networks, where stable, scalable, and versatile quantum nodes are essential.
Quantum dots are nanoscale objects with unique optical and electronic properties that come from quantum mechanical effects. These systems are already used in technologies ...
New avenues in quantum research: supramolecular qubit candidates detected
2025-01-28
Qubits are the basic building blocks of information processing in quantum technology. An important research question is what material they will actually consist of in technical applications. Molecular spin qubits are considered promising qubit candidates for molecular spintronics, in particular for quantum sensing. The materials studied here can be stimulated by light; this creates a second spin centre and, subsequently, a light-induced quartet state. Until now, research has assumed that the interaction between two spin centres can only be strong enough for ...
2024 ISS National Lab Annual Report highlights momentum in space-based R&D
2025-01-28
KENNEDY SPACE CENTER (FL), January 28, 2025 – The International Space Station (ISS) National Laboratory highlighted the rapid growth of space-based R&D in its annual report, released today by the Center for the Advancement of Science in Space® (CASIS®). Over the past fiscal year, the ISS National Lab sponsored more than 100 payloads delivered to the orbiting laboratory—the second-highest annual total to date. Also this year, ISS National Lab-related results were published in 51 peer-reviewed articles—the most ever in a year—underscoring the vital role of the ISS National Lab in advancing scientific discovery and innovation.
Since 2011, ...
New clues to the mechanism behind food tolerance and allergies
2025-01-28
With every bite of food we take, our intestinal immune system must make a big decision. Tasked with defending us from foreign pathogens, these exquisitely sensitive cells somehow distinguish friend from foe—destroying invaders while tolerating food and helpful bacteria. How the gut separates the good from the bad has long puzzled scientists.
Now, new research identifies specific gut cell types that communicate with T cells—prompting them to tolerate, attack, or simply ignore—and explains how these opposing responses are triggered. The findings, published in Science, give scientists ...
Leveraging artificial intelligence for vaccine development: A Ragon-MIT advancement in T cell epitope prediction
2025-01-28
Cambridge, Mass.— An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell vaccine candidates.
Ragon faculty member Gaurav Gaiha, MD, DPhil, and MIT Professor Regina Barzilay, PhD, AI lead of the Jameel Clinic for AI and Health, have published research in Nature Machine Intelligence introducing MUNIS—a deep learning tool designed to predict CD8+ T cell epitopes with unprecedented accuracy. This advancement has the potential to accelerate vaccine development against various ...
Moffitt Research advocates for routine brain MRI screening in asymptomatic late stage breast cancer patients
2025-01-28
TAMPA, Fla. (Jan. 28, 2025) — A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study, published in Neuro-Oncology, suggests that doctors may need to rethink current screening guidelines for detecting brain metastasis in patients without symptoms.
Researchers examined 101 asymptomatic patients diagnosed with stage 4 breast cancer, including triple-negative, HER2-positive and hormone receptor-positive/HER2-negative ...